ProShare Advisors
HUMA icon

ProShare Advisors’s Humacyte HUMA Stock Holding History

ProShare Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,125
Closed -$19.5K – 1963
2026
Q1 		$19.5K Sell
32,125
-4,498
-12% -$4.68K ﹤0.01% 1838
2025
Q4 		$35.2K Buy
36,623
+9,551
+35% +$13.5K ﹤0.01% 1984
2025
Q3 		$47.1K Sell
27,072
-4,421
-14% -$8.66K ﹤0.01% 1940
2025
Q2 		$65.8K Buy
31,493
+6,106
+24% +$11.7K ﹤0.01% 1955
2025
Q1 		$43.3K Sell
25,387
-5,465
-18% -$20.5K ﹤0.01% 1966
2024
Q4 		$156K Buy
30,852
+7,188
+30% +$35.6K ﹤0.01% 1961
2024
Q3 		$129K Buy
23,664
+8,110
+52% +$53.5K ﹤0.01% 1844
2024
Q2 		$74.7K Sell
15,554
-2,708
-15% -$14.1K ﹤0.01% 1699
2024
Q1 		$56.8K Buy
18,262
+1,509
+9% +$5.07K ﹤0.01% 1889
2023
Q4 		$47.6K Buy
16,753
+2,036
+14% +$5.23K ﹤0.01% 1867
2023
Q3 		$43.1K Buy
14,717
+67
+0.5% +$222 ﹤0.01% 1727
2023
Q2 		$41.9K Buy
14,650
+582
+4% +$2.1K ﹤0.01% 1787
2023
Q1 		$43.5K Sell
14,068
-2,025
-13% -$5.76K ﹤0.01% 1683
2022
Q4 		$34K Buy
16,093
+5,483
+52% +$16.6K ﹤0.01% 1771
2022
Q3 		$34K Buy
10,610
+606
+6% +$2.32K ﹤0.01% 1690
2022
Q2 		$32K Sell
10,004
-656
-6% -$3.65K ﹤0.01% 1747
2022
Q1 		$75K Sell
10,660
-3,846
-27% -$22.4K ﹤0.01% 2076
2021
Q4 		$105K Buy
+14,506
New +$143K ﹤0.01% 2195

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

ProShare Advisors's HUMA Position: Q2 2026 in Review

ProShare Advisors sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 32,125 shares — an estimated $19.5K sold.

ProShare Advisors first reported a position in HUMA in Q4 2021 and held it in 18 quarters. The position peaked at $156K in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • ProShare Advisors reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • ProShare Advisors sold 32,125 Humacyte shares in Q2 2026, an estimated $19.5K.
  • ProShare Advisors first reported a position in Humacyte in Q4 2021 and held it in 18 quarters.
  • ProShare Advisors's Humacyte position peaked at $156K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.